{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:51:05Z","timestamp":1793508665226,"version":"4.5.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA276432"],"award-info":[{"award-number":["R01CA276432"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR160009"],"award-info":[{"award-number":["RR160009"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metastatic tumor cell dissemination is the leading cause of cancer-related deaths. Clustered circulating tumor cells (CTCs) possess higher metastatic potential than single CTCs. Epithelial adherens junction (AJ) proteins typically mediate stable cell-cell interactions; however, these proteins are frequently lost in highly aggressive triple-negative breast cancers (TNBCs), raising the question of how CTCs from such tumors cluster. Here we show that the extracellular matrix (ECM) component hyaluronan (HA) mediates AJ-independent CTC clustering in TNBCs. HA is necessary and sufficient to drive clustering of tumor cells expressing its receptor CD44. Mechanistically, HA initiates contact between neighboring cells through actin-based membrane protrusions. As cells are pulled closer, these initial interactions expand to membrane-membrane contact\u00a0and are subsequently stabilized by desmosomes. CTC-derived HA also acts as a docking platform to\u00a0promote heterotypic cluster formation by recruiting non-CTCs, including immune cells.\u00a0Thus, this ECM\u2013receptor interaction enables CTC clustering and survival under shear stress, enhancing TNBC metastasis.<\/jats:p>","DOI":"10.1038\/s41467-026-69007-w","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T10:02:55Z","timestamp":1770372175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Extracellular matrix mediates circulating tumor cell clustering in triple-negative breast cancer metastasis"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2953-9256","authenticated-orcid":false,"given":"Georg OM","family":"Bobkov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9964-5359","authenticated-orcid":false,"given":"Khushali J.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5009-4143","authenticated-orcid":false,"given":"Bree M.","family":"Lege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0532-0551","authenticated-orcid":false,"given":"Gad","family":"Shaulsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5760-2008","authenticated-orcid":false,"given":"Chonghui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"69007_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2406-y","volume":"16","author":"S Jansson","year":"2016","unstructured":"Jansson, S., Bendahl, P. O., Larsson, A. M., Aaltonen, K. E. & Ryden, L. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort. BMC Cancer 16, 433 (2016).","journal-title":"BMC Cancer"},{"key":"69007_CR2","doi-asserted-by":"publisher","first-page":"18392","DOI":"10.1073\/pnas.1012539107","volume":"107","author":"SL Stott","year":"2010","unstructured":"Stott, S. L. et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc. Natl. Acad. Sci. USA 107, 18392\u201318397 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69007_CR3","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-019-0915-y","volume":"566","author":"BM Szczerba","year":"2019","unstructured":"Szczerba, B. M. et al. Neutrophils escort circulating tumour cells to enable cell cycle progression. Nature 566, 553\u2013557 (2019).","journal-title":"Nature"},{"key":"69007_CR4","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nmeth.3404","volume":"12","author":"AF Sarioglu","year":"2015","unstructured":"Sarioglu, A. F. et al. A microfluidic device for label-free, physical capture of circulating tumor cell clusters. Nat. Methods 12, 685\u2013691 (2015).","journal-title":"Nat. Methods"},{"key":"69007_CR5","doi-asserted-by":"publisher","unstructured":"Lim, M. et al. Circulating tumor cell clusters are cloaked with platelets and correlate with poor prognosis in unresectable pancreatic cancer. Cancers 13 https:\/\/doi.org\/10.3390\/cancers13215272 (2021).","DOI":"10.3390\/cancers13215272"},{"key":"69007_CR6","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1039\/C7LC00654C","volume":"17","author":"X Jiang","year":"2017","unstructured":"Jiang, X. et al. Microfluidic isolation of platelet-covered circulating tumor cells. Lab Chip 17, 3498\u20133503 (2017).","journal-title":"Lab Chip"},{"key":"69007_CR7","doi-asserted-by":"publisher","first-page":"21677","DOI":"10.1073\/pnas.1016234107","volume":"107","author":"DG Duda","year":"2010","unstructured":"Duda, D. G. et al. Malignant cells facilitate lung metastasis by bringing their own soil. Proc. Natl. Acad. Sci. USA 107, 21677\u201321682 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69007_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10549-021-06299-0","volume":"189","author":"U Sharma","year":"2021","unstructured":"Sharma, U. et al. Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis. Breast Cancer Res. Treat. 189, 63\u201380 (2021).","journal-title":"Breast Cancer Res. Treat."},{"key":"69007_CR9","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","volume":"158","author":"N Aceto","year":"2014","unstructured":"Aceto, N. et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158, 1110\u20131122 (2014).","journal-title":"Cell"},{"key":"69007_CR10","doi-asserted-by":"publisher","first-page":"E854","DOI":"10.1073\/pnas.1508541113","volume":"113","author":"KJ Cheung","year":"2016","unstructured":"Cheung, K. J. et al. Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters. Proc. Natl. Acad. Sci. USA 113, E854\u2013863 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69007_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1158\/2159-8290.CD-18-0065","volume":"9","author":"X Liu","year":"2019","unstructured":"Liu, X. et al. Homophilic CD44 interactions mediate tumor cell aggregation and polyclonal metastasis in patient-derived breast cancer models. Cancer Discov. 9, 96\u2013113 (2019).","journal-title":"Cancer Discov."},{"key":"69007_CR12","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41577-023-00836-2","volume":"23","author":"AL Correia","year":"2023","unstructured":"Correia, A. L. Locally sourced: site-specific immune barriers to metastasis. Nat. Rev. Immunol. 23, 522\u2013538 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"69007_CR13","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/nrc3628","volume":"13","author":"N Reymond","year":"2013","unstructured":"Reymond, N., d\u2019Agua, B. B. & Ridley, A. J. Crossing the endothelial barrier during metastasis. Nat. Rev. Cancer 13, 858\u2013870 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"69007_CR14","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.cell.2013.11.029","volume":"155","author":"KJ Cheung","year":"2013","unstructured":"Cheung, K. J., Gabrielson, E., Werb, Z. & Ewald, A. J. Collective invasion in breast cancer requires a conserved basal epithelial program. Cell 155, 1639\u20131651 (2013).","journal-title":"Cell"},{"key":"69007_CR15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10549-015-3485-1","volume":"152","author":"SY Cheung","year":"2015","unstructured":"Cheung, S. Y. et al. Role of epithelial-mesenchymal transition markers in triple-negative breast cancer. Breast Cancer Res. Treat. 152, 489\u2013498 (2015).","journal-title":"Breast Cancer Res. Treat."},{"key":"69007_CR16","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.humpath.2015.05.010","volume":"46","author":"MH Jang","year":"2015","unstructured":"Jang, M. H., Kim, H. J., Kim, E. J., Chung, Y. R. & Park, S. Y. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome. Hum. Pathol. 46, 1267\u20131274 (2015).","journal-title":"Hum. Pathol."},{"key":"69007_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/sj.bjc.6605735","volume":"103","author":"S Kashiwagi","year":"2010","unstructured":"Kashiwagi, S. et al. Significance of E-cadherin expression in triple-negative breast cancer. Br. J. Cancer 103, 249\u2013255 (2010).","journal-title":"Br. J. Cancer"},{"key":"69007_CR18","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1073\/pnas.1018862108","volume":"109","author":"JI Herschkowitz","year":"2012","unstructured":"Herschkowitz, J. I. et al. Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells. Proc. Natl. Acad. Sci. USA 109, 2778\u20132783 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69007_CR19","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1038\/sj.onc.1208423","volume":"24","author":"S Maschler","year":"2005","unstructured":"Maschler, S. et al. Tumor cell invasiveness correlates with changes in integrin expression and localization. Oncogene 24, 2032\u20132041 (2005).","journal-title":"Oncogene"},{"key":"69007_CR20","doi-asserted-by":"publisher","first-page":"31393","DOI":"10.1074\/jbc.M112.357624","volume":"287","author":"N Mise","year":"2012","unstructured":"Mise, N. et al. Zyxin is a transforming growth factor-beta (TGF-beta)\/Smad3 target gene that regulates lung cancer cell motility via integrin alpha5beta1. J. Biol. Chem. 287, 31393\u201331405 (2012).","journal-title":"J. Biol. Chem."},{"key":"69007_CR21","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1242\/jcs.099697","volume":"125","author":"RY Huang","year":"2012","unstructured":"Huang, R. Y., Guilford, P. & Thiery, J. P. Early events in cell adhesion and polarity during epithelial-mesenchymal transition. J. Cell Sci. 125, 4417\u20134422 (2012).","journal-title":"J. Cell Sci."},{"key":"69007_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.969787","volume":"12","author":"EL Ivanova","year":"2022","unstructured":"Ivanova, E. L. et al. CD44 expressed by myeloid cells promotes glioma invasion. Front Oncol. 12, 969787 (2022).","journal-title":"Front Oncol."},{"key":"69007_CR23","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1084\/jem.20042014","volume":"201","author":"Y Katayama","year":"2005","unstructured":"Katayama, Y., Hidalgo, A. S., Chang, J., Peired, A. & Frenette, P. S. CD44 is a physiological E-selectin ligand on neutrophils. J. Exp. Med. 201, 1183\u20131189 (2005).","journal-title":"J. Exp. Med."},{"key":"69007_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/stem.1556","volume":"32","author":"Y Kinugasa","year":"2014","unstructured":"Kinugasa, Y., Matsui, T. & Takakura, N. CD44 expressed on cancer-associated fibroblasts is a functional molecule supporting the stemness and drug resistance of malignant cancer cells in the tumor microenvironment. Stem Cells 32, 145\u2013156 (2014).","journal-title":"Stem Cells"},{"key":"69007_CR25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.15407\/fz62.02.094","volume":"62","author":"NG Zemlianskykh","year":"2016","unstructured":"Zemlianskykh, N. G. & Babijchuk, L. A. Changes in erythrocyte surface marker Cd44 during hypothermic and low temperature storage. Fiziol. Zh. 62, 94\u2013102 (2016).","journal-title":"Fiziol. Zh."},{"key":"69007_CR26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1182\/blood.V84.2.390.390","volume":"84","author":"I Koshiishi","year":"1994","unstructured":"Koshiishi, I., Shizari, M. & Underhill, C. B. CD44 can mediate the adhesion of platelets to hyaluronan. Blood 84, 390\u2013396 (1994).","journal-title":"Blood"},{"key":"69007_CR27","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.celrep.2014.08.029","volume":"8","author":"DT Ting","year":"2014","unstructured":"Ting, D. T. et al. Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells. Cell Rep. 8, 1905\u20131918 (2014).","journal-title":"Cell Rep."},{"key":"69007_CR28","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1126\/science.1228522","volume":"339","author":"M Yu","year":"2013","unstructured":"Yu, M. et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339, 580\u2013584 (2013).","journal-title":"Science"},{"key":"69007_CR29","doi-asserted-by":"publisher","unstructured":"Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J. & Werb, Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat. Commun. 11 https:\/\/doi.org\/10.1038\/s41467-020-18794-x (2020).","DOI":"10.1038\/s41467-020-18794-x"},{"key":"69007_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.addr.2015.12.017","volume":"97","author":"J Insua-Rodriguez","year":"2016","unstructured":"Insua-Rodriguez, J. & Oskarsson, T. The extracellular matrix in breast cancer. Adv. Drug Deliv. Rev. 97, 41\u201355 (2016).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"69007_CR31","doi-asserted-by":"publisher","unstructured":"Kobayashi, T., Chanmee, T. & Itano, N. Hyaluronan: metabolism and function. Biomolecules 10 https:\/\/doi.org\/10.3390\/biom10111525 (2020).","DOI":"10.3390\/biom10111525"},{"key":"69007_CR32","doi-asserted-by":"publisher","first-page":"36777","DOI":"10.1074\/jbc.R700036200","volume":"282","author":"PH Weigel","year":"2007","unstructured":"Weigel, P. H. & DeAngelis, P. L. Hyaluronan synthases: a decade-plus of novel glycosyltransferases. J. Biol. Chem. 282, 36777\u201336781 (2007).","journal-title":"J. Biol. Chem."},{"key":"69007_CR33","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3389\/fimmu.2015.00236","volume":"6","author":"KL Schwertfeger","year":"2015","unstructured":"Schwertfeger, K. L., Cowman, M. K., Telmer, P. G., Turley, E. A. & McCarthy, J. B. Hyaluronan, inflammation, and breast cancer progression. Front. Immunol. 6, 236 (2015).","journal-title":"Front. Immunol."},{"key":"69007_CR34","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1158\/0008-5472.CAN-11-1678","volume":"72","author":"H Okuda","year":"2012","unstructured":"Okuda, H. et al. Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells. Cancer Res. 72, 537\u2013547 (2012).","journal-title":"Cancer Res."},{"key":"69007_CR35","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.jvs.2005.01.020","volume":"41","author":"A Dardik","year":"2005","unstructured":"Dardik, A. et al. Differential effects of orbital and laminar shear stress on endothelial cells. J. Vasc. Surg. 41, 869\u2013880 (2005).","journal-title":"J. Vasc. Surg."},{"key":"69007_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ijcard.2006.03.035","volume":"113","author":"TG Papaioannou","year":"2006","unstructured":"Papaioannou, T. G., Karatzis, E. N., Vavuranakis, M., Lekakis, J. P. & Stefanadis, C. Assessment of vascular wall shear stress and implications for atherosclerotic disease. Int. J. Cardiol. 113, 12\u201318 (2006).","journal-title":"Int. J. Cardiol."},{"key":"69007_CR37","doi-asserted-by":"publisher","first-page":"8152","DOI":"10.1158\/1078-0432.CCR-04-1110","volume":"10","author":"S Meng","year":"2004","unstructured":"Meng, S. et al. Circulating tumor cells in patients with breast cancer dormancy. Clin. Cancer Res. 10, 8152\u20138162 (2004).","journal-title":"Clin. Cancer Res."},{"key":"69007_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25917-5","volume":"12","author":"B Hamza","year":"2021","unstructured":"Hamza, B. et al. Measuring kinetics and metastatic propensity of CTCs by blood exchange between mice. Nat. Commun. 12, 5680 (2021).","journal-title":"Nat. Commun."},{"key":"69007_CR39","doi-asserted-by":"publisher","first-page":"a002899","DOI":"10.1101\/cshperspect.a002899","volume":"1","author":"W Meng","year":"2009","unstructured":"Meng, W. & Takeichi, M. Adherens junction: molecular architecture and regulation. Cold Spring Harb. Perspect. Biol. 1, a002899 (2009).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"69007_CR40","doi-asserted-by":"publisher","first-page":"1848212","DOI":"10.1080\/21688370.2020.1848212","volume":"9","author":"MS Adil","year":"2021","unstructured":"Adil, M. S., Narayanan, S. P. & Somanath, P. R. Cell-cell junctions: structure and regulation in physiology and pathology. Tissue Barriers 9, 1848212 (2021).","journal-title":"Tissue Barriers"},{"key":"69007_CR41","doi-asserted-by":"publisher","first-page":"25085","DOI":"10.1074\/jbc.274.35.25085","volume":"274","author":"N Itano","year":"1999","unstructured":"Itano, N. et al. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J. Biol. Chem. 274, 25085\u201325092 (1999).","journal-title":"J. Biol. Chem."},{"key":"69007_CR42","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1074\/jbc.273.1.338","volume":"273","author":"J Bajorath","year":"1998","unstructured":"Bajorath, J., Greenfield, B., Munro, S. B., Day, A. J. & Aruffo, A. Identification of CD44 residues important for hyaluronan binding and delineation of the binding site. J. Biol. Chem. 273, 338\u2013343 (1998).","journal-title":"J. Biol. Chem."},{"key":"69007_CR43","doi-asserted-by":"publisher","first-page":"23772","DOI":"10.18632\/oncotarget.8180","volume":"7","author":"C Aguirre-Alvarado","year":"2016","unstructured":"Aguirre-Alvarado, C. et al. Virtual screening-driven repositioning of etoposide as CD44 antagonist in breast cancer cells. Oncotarget 7, 23772\u201323784 (2016).","journal-title":"Oncotarget"},{"key":"69007_CR44","doi-asserted-by":"publisher","unstructured":"Svitkina, T. The actin cytoskeleton and actin-based motility. Cold Spring Harb Perspect Biol 10 https:\/\/doi.org\/10.1101\/cshperspect.a018267 (2018).","DOI":"10.1101\/cshperspect.a018267"},{"key":"69007_CR45","first-page":"2091","volume":"29","author":"H Konishi","year":"2009","unstructured":"Konishi, H. et al. Latrunculin a has a strong anticancer effect in a peritoneal dissemination model of human gastric cancer in mice. Anticancer Res. 29, 2091\u20132097 (2009).","journal-title":"Anticancer Res."},{"key":"69007_CR46","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0092-8674(00)81559-7","volume":"100","author":"V Vasioukhin","year":"2000","unstructured":"Vasioukhin, V., Bauer, C., Yin, M. & Fuchs, E. Directed actin polymerization is the driving force for epithelial cell-cell adhesion. Cell 100, 209\u2013219 (2000).","journal-title":"Cell"},{"key":"69007_CR47","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S0955-0674(00)00177-0","volume":"13","author":"V Vasioukhin","year":"2001","unstructured":"Vasioukhin, V. & Fuchs, E. Actin dynamics and cell-cell adhesion in epithelia. Curr. Opin. Cell Biol. 13, 76\u201384 (2001).","journal-title":"Curr. Opin. Cell Biol."},{"key":"69007_CR48","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41580-023-00688-7","volume":"25","author":"O Campas","year":"2024","unstructured":"Campas, O., Noordstra, I. & Yap, A. S. Adherens junctions as molecular regulators of emergent tissue mechanics. Nat. Rev. Mol. Cell Biol. 25, 252\u2013269 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"69007_CR49","doi-asserted-by":"publisher","unstructured":"Perl, A. L., Pokorny, J. L. & Green, K. J. Desmosomes at a glance. J. Cell Sci. 137 https:\/\/doi.org\/10.1242\/jcs.261899 (2024).","DOI":"10.1242\/jcs.261899"},{"key":"69007_CR50","doi-asserted-by":"publisher","unstructured":"Chang, P. H. et al. Interplay between desmoglein2 and hypoxia controls metastasis in breast cancer. Proc. Natl. Acad. Sci. USA 118 https:\/\/doi.org\/10.1073\/pnas.2014408118 (2021).","DOI":"10.1073\/pnas.2014408118"},{"key":"69007_CR51","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg7265","volume":"7","author":"K Li","year":"2021","unstructured":"Li, K., Wu, R., Zhou, M., Tong, H. & Luo, K. Q. Desmosomal proteins of DSC2 and PKP1 promote cancer cells survival and metastasis by increasing cluster formation in circulatory system. Sci. Adv. 7, eabg7265 (2021).","journal-title":"Sci. Adv."},{"key":"69007_CR52","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1159\/000516574","volume":"211","author":"SR Brown","year":"2022","unstructured":"Brown, S. R., Bates, J. C., Avera, A. D. & Kim, Y. Relationship between stemness, reactive oxygen species, and epithelial-to-mesenchymal transition in model circulating tumor cells. Cells Tissues Organs 211, 282\u2013293 (2022).","journal-title":"Cells Tissues Organs"},{"key":"69007_CR53","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1002\/jcp.26016","volume":"233","author":"Y Chao","year":"2018","unstructured":"Chao, Y. et al. Low shear stress induces endothelial reactive oxygen species via the AT1R\/eNOS\/NO pathway. J. Cell Physiol. 233, 1384\u20131395 (2018).","journal-title":"J. Cell Physiol."},{"key":"69007_CR54","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1161\/01.ATV.17.12.3570","volume":"17","author":"JJ Chiu","year":"1997","unstructured":"Chiu, J. J., Wung, B. S., Shyy, J. Y., Hsieh, H. J. & Wang, D. L. Reactive oxygen species are involved in shear stress-induced intercellular adhesion molecule-1 expression in endothelial cells. Arterioscler Thromb. Vasc. Biol. 17, 3570\u20133577 (1997).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"69007_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12412-1","volume":"10","author":"I Godet","year":"2019","unstructured":"Godet, I. et al. Fate-mapping post-hypoxic tumor cells reveals a ROS-resistant phenotype that promotes metastasis. Nat. Commun. 10, 4862 (2019).","journal-title":"Nat. Commun."},{"key":"69007_CR56","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.cmet.2019.07.014","volume":"30","author":"CF Labuschagne","year":"2019","unstructured":"Labuschagne, C. F., Cheung, E. C., Blagih, J., Domart, M.-C. & Vousden, K. H. Cell clustering promotes a metabolic switch that supports metastatic colonization. Cell Metab. 30, 720\u2013734.e725 (2019).","journal-title":"Cell Metab."},{"key":"69007_CR57","first-page":"1347","volume":"43","author":"K Kimata","year":"1983","unstructured":"Kimata, K. et al. Increased synthesis of hyaluronic acid by mouse mammary carcinoma cell variants with high metastatic potential. Cancer Res. 43, 1347\u20131354 (1983).","journal-title":"Cancer Res."},{"key":"69007_CR58","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/ijc.22550","volume":"120","author":"Y Li","year":"2007","unstructured":"Li, Y., Li, L., Brown, T. J. & Heldin, P. Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells. Int. J. Cancer 120, 2557\u20132567 (2007).","journal-title":"Int. J. Cancer"},{"key":"69007_CR59","first-page":"428","volume":"55","author":"L Zhang","year":"1995","unstructured":"Zhang, L., Underhill, C. B. & Chen, L. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res. 55, 428\u2013433 (1995).","journal-title":"Cancer Res."},{"key":"69007_CR60","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1111\/cas.14070","volume":"110","author":"YH Kim","year":"2019","unstructured":"Kim, Y. H. et al. Hyaluronic acid synthase 2 promotes malignant phenotypes of colorectal cancer cells through transforming growth factor beta signaling. Cancer Sci. 110, 2226\u20132236 (2019).","journal-title":"Cancer Sci."},{"key":"69007_CR61","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack, I. & Shaw, A. T. Tumour heterogeneity and resistance to cancer therapies. Nat. Rev. Clin. Oncol. 15, 81\u201394 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"69007_CR62","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1158\/0008-5472.CAN-16-2545","volume":"77","author":"S Liu","year":"2017","unstructured":"Liu, S. & Cheng, C. Akt signaling is sustained by a CD44 splice isoform-mediated positive feedback loop. Cancer Res. 77, 3791\u20133801 (2017).","journal-title":"Cancer Res."},{"key":"69007_CR63","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.2353\/ajpath.2009.080501","volume":"174","author":"AG Bharadwaj","year":"2009","unstructured":"Bharadwaj, A. G. et al. Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing. Am. J. Pathol. 174, 1027\u20131036 (2009).","journal-title":"Am. J. Pathol."},{"key":"69007_CR64","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.3109\/10428194.2011.569962","volume":"52","author":"Y Herishanu","year":"2011","unstructured":"Herishanu, Y. et al. Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1. Leuk. Lymphoma 52, 1758\u20131769 (2011).","journal-title":"Leuk. Lymphoma"},{"key":"69007_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03037-0","volume":"11","author":"C Yang","year":"2020","unstructured":"Yang, C. et al. CD44\/HA signaling mediates acquired resistance to a PI3Kalpha inhibitor. Cell Death Dis. 11, 831 (2020).","journal-title":"Cell Death Dis."},{"key":"69007_CR66","doi-asserted-by":"publisher","unstructured":"Hellicar, J., Stevenson, N. L., Stephens, D. J. & Lowe, M. Supply chain logistics - the role of the Golgi complex in extracellular matrix production and maintenance. J. Cell Sci. 135 https:\/\/doi.org\/10.1242\/jcs.258879 (2022).","DOI":"10.1242\/jcs.258879"},{"key":"69007_CR67","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41586-019-1526-3","volume":"573","author":"V Padmanaban","year":"2019","unstructured":"Padmanaban, V. et al. E-cadherin is required for metastasis in multiple models of breast cancer. Nature 573, 439\u2013444 (2019).","journal-title":"Nature"},{"key":"69007_CR68","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1038\/onc.2012.475","volume":"32","author":"H Porsch","year":"2013","unstructured":"Porsch, H. et al. Efficient TGFbeta-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2. Oncogene 32, 4355\u20134365 (2013).","journal-title":"Oncogene"},{"key":"69007_CR69","doi-asserted-by":"publisher","first-page":"11530","DOI":"10.18632\/oncotarget.14563","volume":"8","author":"BT Preca","year":"2017","unstructured":"Preca, B. T. et al. A novel ZEB1\/HAS2 positive feedback loop promotes EMT in breast cancer. Oncotarget 8, 11530\u201311543 (2017).","journal-title":"Oncotarget"},{"key":"69007_CR70","doi-asserted-by":"publisher","first-page":"a002998","DOI":"10.1101\/cshperspect.a002998","volume":"1","author":"M Cavey","year":"2009","unstructured":"Cavey, M. & Lecuit, T. Molecular bases of cell-cell junctions stability and dynamics. Cold Spring Harb. Perspect. Biol. 1, a002998 (2009).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"69007_CR71","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nrc1391","volume":"4","author":"BP Toole","year":"2004","unstructured":"Toole, B. P. Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer 4, 528\u2013539 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"69007_CR72","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1083\/jcb.140.2.431","volume":"140","author":"TP Skelton","year":"1998","unstructured":"Skelton, T. P., Zeng, C., Nocks, A. & Stamenkovic, I. Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J. Cell Biol. 140, 431\u2013446 (1998).","journal-title":"J. Cell Biol."},{"key":"69007_CR73","doi-asserted-by":"publisher","first-page":"26967","DOI":"10.1016\/S0021-9258(19)61467-5","volume":"275","author":"J Lesley","year":"2000","unstructured":"Lesley, J., Hascall, V. C., Tammi, M. & Hyman, R. Hyaluronan binding by cell surface CD44. J. Biol. Chem. 275, 26967\u201326975 (2000).","journal-title":"J. Biol. Chem."},{"key":"69007_CR74","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.1073\/pnas.1524448113","volume":"113","author":"SH Au","year":"2016","unstructured":"Au, S. H. et al. Clusters of circulating tumor cells traverse capillary-sized vessels. PNAS 113, 4947\u20134952 (2016).","journal-title":"PNAS"},{"key":"69007_CR75","doi-asserted-by":"publisher","unstructured":"Chernet, D. Y., Klassen, L., Goertzen, S. & Malagon, J. N. Live imaging and quantification of circulating potentially metastatic tumor cells in early pupal stage of Drosophila melanogaster. MicroPubl Biol. 2022 https:\/\/doi.org\/10.17912\/micropub.biology.000588 (2022).","DOI":"10.17912\/micropub.biology.000588"},{"key":"69007_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35646-3","volume":"8","author":"B Nath","year":"2018","unstructured":"Nath, B. et al. Understanding flow dynamics, viability and metastatic potency of cervical cancer (HeLa) cells through constricted microchannel. Sci. Rep. 8, 17357 (2018).","journal-title":"Sci. Rep."},{"key":"69007_CR77","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1158\/0008-5472.CAN-17-2748","volume":"78","author":"M Giuliano","year":"2018","unstructured":"Giuliano, M. et al. Perspective on circulating tumor cell clusters: why it takes a village to metastasize. Cancer Res. 78, 845\u2013852 (2018).","journal-title":"Cancer Res."},{"key":"69007_CR78","doi-asserted-by":"publisher","unstructured":"Hassn Mesrati, M., Syafruddin, S. E., Mohtar, M. A. & Syahir, A. CD44: a multifunctional mediator of cancer progression. Biomolecules 11 https:\/\/doi.org\/10.3390\/biom11121850 (2021).","DOI":"10.3390\/biom11121850"},{"key":"69007_CR79","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mehy.2015.12.007","volume":"87","author":"Q Liu","year":"2016","unstructured":"Liu, Q., Liao, Q. & Zhao, Y. Myeloid-derived suppressor cells (MDSC) facilitate distant metastasis of malignancies by shielding circulating tumor cells (CTC) from immune surveillance. Med. Hypotheses 87, 34\u201339 (2016).","journal-title":"Med. Hypotheses"},{"key":"69007_CR80","doi-asserted-by":"publisher","unstructured":"Sprouse, M. L. et al. PMN-MDSCs enhance CTC metastatic properties through reciprocal interactions via ROS\/Notch\/Nodal signaling. Int. J. Mol Sci. 20 https:\/\/doi.org\/10.3390\/ijms20081916 (2019).","DOI":"10.3390\/ijms20081916"},{"key":"69007_CR81","doi-asserted-by":"publisher","unstructured":"Hurtado, P., Martinez-Pena, I. & Pineiro, R. Dangerous liaisons: circulating tumor cells (CTCs) and cancer-associated fibroblasts (CAFs). Cancers 12 https:\/\/doi.org\/10.3390\/cancers12102861 (2020).","DOI":"10.3390\/cancers12102861"},{"key":"69007_CR82","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fonc.2018.00107","volume":"8","author":"P Kanikarla-Marie","year":"2018","unstructured":"Kanikarla-Marie, P. et al. Platelet metabolism and other targeted drugs: potential impact on immunotherapy. Front. Oncol. 8, 107 (2018).","journal-title":"Front. Oncol."},{"key":"69007_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.640578","volume":"12","author":"L Schmied","year":"2021","unstructured":"Schmied, L., Hoglund, P. & Meinke, S. Platelet-mediated protection of cancer cells from immune surveillance - possible implications for cancer immunotherapy. Front. Immunol. 12, 640578 (2021).","journal-title":"Front. Immunol."},{"key":"69007_CR84","doi-asserted-by":"publisher","unstructured":"Liu, S. & Cheng, C. Akt signaling is sustained by a CD44 splice isoform-mediated positive feedback loop. Cancer Res. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2545 (2017).","DOI":"10.1158\/0008-5472.CAN-16-2545"},{"key":"69007_CR85","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1002\/stem.1752","volume":"32","author":"W Wei","year":"2014","unstructured":"Wei, W. et al. STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer. Stem Cells 32, 2571\u20132582 (2014).","journal-title":"Stem Cells"},{"key":"69007_CR86","doi-asserted-by":"publisher","unstructured":"Wang, W. et al. Internalized CD44s splice isoform attenuates EGFR degradation by targeting Rab7A. PNAS https:\/\/doi.org\/10.1073\/pnas.1701289114 (2017).","DOI":"10.1073\/pnas.1701289114"},{"key":"69007_CR87","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783\u2013784 (2014).","journal-title":"Nat. Methods"},{"key":"69007_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11479","volume":"7","author":"B Pereira","year":"2016","unstructured":"Pereira, B. et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat. Commun. 7, 11479 (2016).","journal-title":"Nat. Commun."},{"key":"69007_CR89","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1007-8","volume":"567","author":"OM Rueda","year":"2019","unstructured":"Rueda, O. M. et al. Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups. Nature 567, 399\u2013404 (2019).","journal-title":"Nature"},{"key":"69007_CR90","doi-asserted-by":"publisher","first-page":"W199","DOI":"10.1093\/nar\/gkz401","volume":"47","author":"Y Liao","year":"2019","unstructured":"Liao, Y., Wang, J., Jaehnig, E. J., Shi, Z. & Zhang, B. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 47, W199\u2013W205 (2019).","journal-title":"Nucleic Acids Res."},{"key":"69007_CR91","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69007-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69007-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69007-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T10:02:57Z","timestamp":1770372177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69007-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["69007"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-69007-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.J.E. reports income from Veracyte and Bioclassifier LLC and employment with AstraZeneca unrelated to this work. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1352"}}